Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Rennes
Clinical trial register · France

Clinical Trials in Rennes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Rennes University Hospital46 Nantes University Hospital22 AstraZeneca21 Hoffmann-La Roche16 Merck Sharp & Dohme LLC16
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Rennes

537 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Centre Hospitalier de Saint-Brieuc
Not applicable
280
Dinan, Guingamp, Lannion, Noyal-Pontivy, Paimpol, Rennes, Saint-Brieuc
2027-07
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Strasbourg, Toulouse, Bordeaux, Bron, Paris, Rennes
2027-02-03
Not yet open
Nantes University Hospital
Phase 3
266
Angers, Brest, La Roche-sur-Yon, Nantes, Rennes, Toulouse
2027-01-15
Recruiting
Pôle Saint Hélier
Not applicable
40
Rennes
2027-01-04
Not yet open
Characterization of Muscle Activity During a Surface EMG-controlled Rehabilitation Game
NCT07838688Cerebral Palsy, Hemiparesis; Poststroke/CVA, Healthy (Controls)
Rennes University Hospital
Not applicable
50
Rennes
2027-01-01
Not yet open
Nantes University Hospital
Observational
553
Angers, Bordeaux, Brest, Caen, Chambray-lès-Tours, Le Mans, Nantes, Rennes
2027-01-01
Not yet open
University Hospital, Toulouse
Not applicable
266
Besançon, Créteil, Lyon, Marseille, Nantes, Paris, Rennes, Toulouse
2027-01-01
Not yet open
tDCS and Symptom Provocation in Treatment-Resistant OCD
NCT07429500Obsessive - Compulsive Disorder
Centre Hospitalier Henri Laborit
Not applicable
178
Angoulême, Limoges, Nantes, Poitiers, Rennes, Thouars
2026-12-01
Not yet open
Bristol-Myers Squibb
Phase 2
80
Rennes, Villejuif, Toulouse, Paris
2026-11-30
Not yet open
SUVY VerSus SAccharose (SUVISA)
NCT07901491Healthy Volunteers, Erythritol
Minerais SAS
Not applicable
14
Rennes
2026-11-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 2
30
Bron, Lille, Rennes
2026-11-01
Not yet open
Poitiers University Hospital
Not applicable
778
Angers, Bayonne, La Roche-sur-Yon, La Rochelle, Montpellier, Nancy, Poitiers, Rennes
2026-11
Recruiting
A Study of DS-3939a in Participants With Solid Tumors
NCT07739966Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
DrugsDS-1103a·DS-3939a·Pemetrexed·Carboplatin
Daiichi Sankyo
Phase 1/2
400
Marseille, Montpellier, Paris, Rennes, Saint-Herblain, Suresnes, Vandœuvre-lès-Nancy, Villejuif
2026-10-13
Not yet open
Centre Georges Francois Leclerc
Not applicable
18
Dijon, Montpellier, Rennes, Villejuif
2026-10-01
Not yet open
University Hospital, Grenoble
Not applicable
987
Annecy, Bordeaux, Chambéry, La Roche-sur-Yon, Lyon, Nancy, Nantes, Rennes
2026-10-01
Not yet open
Institut Cancerologie de l'Ouest
Not applicable
167
Angers, Avignon, Brest, La Roche-sur-Yon, Le Havre, Le Mans, Lorient, Rennes
2026-10
Not yet open
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
NCT07902479Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, MOG Antibody-Associated Disease, Demyelinating Autoimmune Diseases, CNS
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
500
Bron, Nantes, Nice, Paris, Rennes
2026-10
Recruiting
Study on the Management of COMISA
NCT07743931Obstructive Sleep Apnea (OSA), Insomnia, COMISA
DrugDaridorexant
University Hospital, Grenoble
Not applicable
150
Grenoble, Marseille, Metz, Paris, Rennes
2026-09-30
Not yet open
UNICANCER
Phase 2
51
Bordeaux, Lyon, Marseille, Nice, Paris, Rennes, Saint-Herblain, Toulouse
2026-09-18
Recruiting
Poitiers University Hospital
Not applicable
460
La Roche-sur-Yon, La Rochelle, Le Mans, Poitiers, Rennes, Saintes, Tours
2026-09-16
Not yet open
Rennes University Hospital
Not applicable
20
Rennes
2026-09-15
Recruiting
CSL Behring
Phase 3
63
Rennes, Nantes, Angers, La Roche-sur-Yon, Rouen
2026-09-15
Recruiting
Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)
NCT07486024MDR-TB, Tuberculosis Multi Drug Resistant Active, Antibiotic Resistance, Mycobacterium Tuberculosis
DrugBedaquiline
Assistance Publique - Hôpitaux de Paris
Phase 3
55
Amiens, Paris, Rennes, Toulouse
2026-09-11
Recruiting
GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA
NCT07639333Miscarriage in First Trimester, Prenatal Genetic Diagnosis
Rennes University Hospital
Not applicable
100
Rennes
2026-09-11
Not yet open
PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics
NCT07527949Traumatic Brain Injury, Magnetic Resonance Imaging (MRI)
Rennes University Hospital
Not applicable
100
Rennes, Toulon
2026-09-01
Not yet open
Stroke Cerebral Reorganization Pathways (SPECTRE)
NCT06784518Brain Diseases, Ischemic Stroke, Stroke, Brain Infarction
Rennes University Hospital
Not applicable
30
Rennes
2026-09-01
Not yet open
Outcome of Patients With Severe Mental Illness in the Intensive Care Unit
NCT07705802Severe Mental Illness, Severe Mental Disorder
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Observational
2,000
Nice, La Rochelle, Quincy-sous-Sénart, Boulogne-Billancourt, Rennes, Blois, Cahors, Vannes
2026-09
Recruiting
Oslo University Hospital
Observational
400
Rennes, Strasbourg
2026-09
Not yet open
University Hospital, Tours
Phase 2
34
Angers, Brest, Marseille, Nantes, Paris, Rennes
2026-09
Not yet open
University of Rennes 2
Not applicable
60
Rennes
2026-09
Recruiting
AstraZeneca
Phase 3
1,072
Bordeaux, Nantes, Paris, Poitiers, Rennes, Strasbourg, Toulouse
2026-08-31
Recruiting
Kardigan, Inc.
Phase 3
332
Chambray-lès-Tours, Lille, Paris, Rennes
2026-08-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bron, Corbeil-Essonnes, La Tronche, Le Coudray, Lens, Metz-Tessy, Pau, Rennes
2026-08-24
Recruiting
Genmab
Phase 1
112
Rennes
2026-08-13
Recruiting
University Hospital, Limoges
Not applicable
187
Bordeaux, Le Chesnay, Lille, Limoges, Poissy, Poitiers, Rennes
2026-08-05
Not yet open
Intravenous Lidocaine for Hepatectomy
NCT07590830Hepatectomy
Rennes University Hospital
Phase 4
312
Clermont-Ferrand, La Roche-sur-Yon, Le Coudray, Lille, Lyon, Nice, Paris, Rennes
2026-08-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
200
Angers, Dieppe, Le Kremlin-Bicêtre, Lyon, Marseille, Rennes, Strasbourg
2026-08-01
Not yet open
ARCAGY/ GINECO GROUP
Phase 1/2
43
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Pierre-Bénite, Rennes
2026-08
Recruiting
CLE-PAD : Prevalence of PAD in Patients With Surgically Lumbar Spinal Stenosis
NCT07469020PAD - Peripheral Arterial Disease, Lumbar Spinal Stenosis, Lower Limb Arterial Disease
Rennes University Hospital
Not applicable
49
Lille, Paris, Rennes
2026-08
Recruiting
Boehringer Ingelheim
Phase 3
448
Bordeaux, Brest, Caen, Epagny Metz-Tessy, Marseille, Nantes, Paris, Rennes
2026-07-27
Recruiting
Nantes University Hospital
Phase 2
142
Angers, Bordeaux, Brest, Dijon, Nantes, Paris, Rennes, Strasbourg
2026-07-16
Recruiting
Centre Hospitalier Departemental Vendee
Not applicable
100
Amiens, Angers, La Roche-sur-Yon, Paris, Rennes
2026-07-10
Recruiting
Boehringer Ingelheim
Phase 3
390
Clichy, Dijon, Lyon, Marseille, Pessac, Rennes, Toulouse, Villejuif
2026-07-10
Recruiting
Center Eugene Marquis
Not applicable
90
Rennes
2026-07-08
Not yet open
Strategies for Weaning From External Ventricular Drainage
NCT07630051Subarachnoid Hemorrhage, Hydrocephalus, Intracranial Hypertension, External Ventricular Drainage
University Hospital, Angers
Not applicable
170
Angers, Brest, Nantes, Poitiers, Rennes
2026-07-01
Recruiting
Center Eugene Marquis
Observational
200
Rennes
2026-06-25
Recruiting
Rhythm Diagnostic Systems
Not applicable
490
Nice, Saint-Etienne, Rennes, Besançon, Reims, Bourgoin, Rouen, Amiens
2026-06-16
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Angers, Brest, Bron, Montpellier, Nice, Paris, Rennes, Tours
2026-06-11
Active, closed
AstraZeneca
Phase 2
326
Créteil, Marseille, Rennes, Toulouse
2026-06-11
Recruiting
Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers
NCT07684911Depression - Major Depressive Disorder, Depression Bipolar, Depression Unipolar
Hospital Center Guillaume Régnier
Observational
30
Rennes
2026-06-04
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Caen, Créteil, Lille, Marseille, Nantes, Paris, Rennes, Toulouse
2026-06-03
Not yet open
Sperm Epigenome in Hodgkin Lymphoma
NCT07449832Hodgkin Disease Lymphoma
Rennes University Hospital
Not applicable
50
Rennes
2026-06-01
Recruiting
PRACOH Prevention Breakdown Support Advice Guidance Disability
NCT07496996Person With a Disability, Caregiver
Pôle Saint Hélier
Not applicable
100
Rennes
2026-05-29
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Brest, Le Kremlin-Bicêtre, Lens, Nîmes, Paris, Pessac, Poitiers, Rennes
2026-05-27
Recruiting
BeOne Medicines
Phase 3
1,056
Bordeaux, Lyon, Marseille, Montpellier, Rennes, SaintHerblain, Villejuif
2026-05-22
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Grenoble, Lyon, Nice, Rennes, Toulouse
2026-05-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Rennes, Suresnes, Clermont-Ferrand
2026-05-04
Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
NCT07436312Breast Cancer, Pancreas Cancer, Colon Cancer, Lynch Syndrome
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
170
Avignon, Rennes, Villejuif
2026-05-04
Recruiting
Echosens
Not applicable
149
Rennes
2026-04-23
Recruiting
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Not applicable
50
Nancy, Rennes
2026-04-15
Recruiting
University Hospital, Brest
Phase 3
406
Brest, Colombes, Créteil, Morlaix, Orléans, Poitiers, Rennes, Tours
2026-04-08
Recruiting
University Hospital, Toulouse
Observational
120
Bordeaux, Caen, Lille, Lyon, Marseille, Paris, Rennes
2026-04-07
Not yet open
Tocilizumab in Chronic Inflammatory CPPD Disease
NCT07254637Calcium Pyrophosphate Deposition Disease
DrugTocilizumab
Assistance Publique - Hôpitaux de Paris
Phase 2
80
Lomme, Paris, Corbeil-Essonnes, Dijon, Nantes, Rennes, Saint-Etienne
2026-04
Recruiting
MICROBIOTA AND BLADDER CANCER
NCT07080333Bladder (Urothelial, Transitional Cell) Cancer
Centre Hospitalier Universitaire de Nice
Not applicable
95
Cannes, Marseille, Menton, Nice, Nîmes, Paris, Rennes, Tours
2026-03-23
Recruiting
SymBio Pharmaceuticals
Phase 3
180
Bordeaux, Lille, Nancy, Nantes, Paris, Rennes, Strasbourg
2026-03-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
298
Clermont-Ferrand, Créteil, Lille, Paris, Rennes, Strasbourg, Toulouse, Vandœuvre-lès-Nancy
2026-03-13
Recruiting
Hospital Center Guillaume Régnier
Observational
22
Rennes
2026-03-13
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Cedex Lyon 08, Paris, Rennes, Strasbourg, Suresnes, Toulouse, Villejuif
2026-03-12
Recruiting
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
NCT07246265Sickle Cell Disease, Glomerular Hyperfiltration, Sickle Cell Nephropathy, Vaso-Occlusive Crises
University Hospital, Tours
Not applicable
100
Tours, Créteil, Le Mans, Nantes, Orléans, Rennes
2026-03-05
Recruiting
Center Eugene Marquis
Not applicable
390
Rennes
2026-03-02
Recruiting
Center Eugene Marquis
Phase 2
80
Grenoble, Lille, Marseille, Montpellier, Nice, Rennes
2026-02-25
Recruiting
Kardigan, Inc.
Phase 2/3
332
Chambray-lès-Tours, Lille, Paris, Rennes
2026-02-13
Recruiting
Study of Alloknesia in Atopic Dermatitis
NCT06923202Atopic Dermatosis, Alloknesie
University Hospital, Brest
Observational
160
Angers, Brest, La Roche-sur-Yon, Lorient, Nantes, Rennes, Tours, Vannes
2026-02-10
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
80
Bron, Lille, Paris, Rennes, Toulouse
2026-02-10
Recruiting
Nantes University Hospital
Phase 3
222
Aix-en-Provence, Angers, Brest, Lille, Lyon, Nantes, Rennes
2026-02-09
Recruiting
AstraZeneca
Phase 3
2,130
Bordeaux, Caen, Lyon, Marseille, Rennes, Villejuif
2026-02-03
Recruiting
Effect of Visual Deprivation of the Team Leader on Team Performance During Simulated Medical Emergencies
NCT07427641High Fidelity Simulation Training, Randomized Controlled Trials, Education, Medical, Continuing, Education, Medical
Rennes University Hospital
Not applicable
54
Rennes
2026-02-02
Recruiting
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
NCT07193394Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer
DrugsTucatinib·Herceptin·Trastuzumab
Institut Curie
Phase 2
20
Bordeaux, Limoges, Marseille, Nice, Nîmes, Rennes, Saint-Cloud, Toulouse
2026-01-31
Recruiting
IDEAYA Biosciences
Phase 3
520
Nice, Bordeaux, Rennes, Paris
2026-01-25
Recruiting
AbbVie
Phase 2
165
Montpellier, Rennes, Bobigny
2026-01-23
Active, closed
CSL Behring
Phase 2
84
Limoges, Marseille, Montpellier, Mulhouse, Pessac, Pierre-Bénite, Rennes, Saint-Brieuc
2026-01-22
Recruiting
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
NCT06254248Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
Assistance Publique - Hôpitaux de Paris
Phase 2
50
Clichy, Créteil, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2026-01-22
Recruiting
Boehringer Ingelheim
Phase 3
400
Bron, Marseille, Nantes, Paris, Rennes, Strasbourg, Toulouse, Villejuif
2026-01-16
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
120
Dijon, Montpellier, Rennes, Saint-Herblain, Lille, Villeurbanne, Rouen, Avignon
2026-01-15
Recruiting
Contineum Therapeutics
Phase 2
324
Nice, Rennes, Bobigny, Amiens, Bron
2026-01-08
By invitation
Medtronic
Observational
2,000
Chambray-lès-Tours, La Tronche, Lille, Montpellier, Pessac, Rennes, Rouen, Toulouse
2026-01-07
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Bordeaux, Clermont-Ferrand, Lille, Lyon, Nîmes, Paris, Rennes, Villejuif
2025-12-19
Recruiting
University Hospital, Angers
Not applicable
300
Angers, Rennes, Tours
2025-12-17
Recruiting
H'ability
Not applicable
44
Berck, Hyères, Ploemeur, Rennes, Roscoff
2025-12-16
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
41
Lyon, Paris, Rennes, Toulouse
2025-12-16
Not yet open
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398Organ Transplantation, Liver Dysfunction, Liver Diseases
Rennes University Hospital
Phase 2
99
Clichy, Lyon, Montpellier, Rennes, Tours, Villejuif
2025-12-15
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
DrugCetuximab
Revolution Medicines, Inc.
Phase 3
500
Lille, Rennes, Villejuif, Marseille
2025-12-15
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Le Mans, Nantes, Orléans, Paris, Pointe à Pitre, Rennes, Tours
2025-12-13
Recruiting
ALX Oncology Inc.
Phase 2
120
Besançon, Bordeaux, Paris, Poitiers, Rennes
2025-12-10
Recruiting
Protara Therapeutics
Phase 2/3
129
Clichy, Rennes, Vandœuvre-lès-Nancy
2025-12-10
Recruiting
Nantes University Hospital
Not applicable
266
Brest, Rennes, Tours, Nantes, Clermont-Ferrand, Rouen, Poitiers
2025-11-25
Recruiting
Momelotinib in VEXAS Syndrome
NCT07098936VEXAS Syndome, Myelo Dysplastic Syndrome
Groupe Francophone des Myelodysplasies
Phase 2
57
Angers, Clermont-Ferrand, Lille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes
2025-11-25
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Brest, Le Kremlin-Bicêtre, Montpellier, Nantes, Paris, Rennes, Tours
2025-11-16
Recruiting
University Hospital, Angers
Not applicable
58
Angers, Brest, Le Mans, Nantes, Rennes, Tours, Vannes
2025-11-04
Recruiting
Eli Lilly and Company
Phase 3
1,205
Angers, Chambray-lès-Tours, Lomme, Nice, Paris, Rennes
2025-10-31
Recruiting
Septodont
Observational
275
Lyon, Nantes, Paris, Rennes
2025-10-23
Recruiting
Institut Claudius Regaud
Phase 4
210
Angers, Dijon, Lille, Marseille, Nîmes, Paris, Rennes, Strasbourg
2025-10-15
Recruiting
Gait and Energy Expenditure in Children With Lower Limb Amputation (MAPEDE)
NCT07076602Amputation of Lower Extremity, All Causes
Rennes University Hospital
Observational
48
Berck, Brest, Bron, Dijon, Lyon, Rennes, Saint-Maurice, Valenton
2025-10-13
Recruiting
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
NCT06618703Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side Effect
University Hospital, Angers
Not applicable
230
Angers, Bron, Rennes
2025-10-10
Recruiting
Genentech, Inc.
Phase 1/2
285
Reims, Villejuif, Caen, Lille, Rennes
2025-10-07
Not yet open
Hospices Civils de Lyon
Not applicable
516
Ivry-sur-Seine, Lille, Lyon, Nantes, Rennes, Saint-Victor-de-Cessieu, Strasbourg, Toulouse
2025-10-01
Not yet open
Rennes University Hospital
Phase 4
246
Angers, Brest, Chartres, Nantes, Poitiers, Rennes, Saint-Nazaire, Tours
2025-10-01
Recruiting
Pfizer
Phase 3
680
Brest, Toulouse, Rennes, Saint-Herblain, Lille, Villejuif, Bordeaux, Marseille
2025-09-29
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bron, Dijon, Lille, Montpellier, Rennes, Tours
2025-09-29
Recruiting
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NCT06960902Familial Hypercholesterolemias, Atherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital
Not applicable
600
Dijon, Lille, Lyon, Marseille, Nantes, Paris, Rennes, Strasbourg
2025-09-25
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Nantes, Nice, Rennes, Saint-Pierre (La Réunion)
2025-09-22
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Le Kremlin Bicétre Cedex, Lille, Marseille, Paris, Rennes, Toulouse, Tours, Vandœuvre-lès-Nancy
2025-09-17
Recruiting
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
NCT07116525Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Ventricular Tachycardia
Biosense Webster, Inc.
Not applicable
90
Pessac, Rennes
2025-09-15
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Angers, Bordeaux, Lille, Paris, Rennes, Strasbourg, Toulouse
2025-09-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Bordeaux, Lyon, Dijon, Toulouse, Montpellier, Rennes, Saint-Herblain, Reims
2025-09-11
Recruiting
Exploratory Study of MRI Biomarkers of NASH
NCT06626074Non-alcoholic Fatty Liver Disease NAFLD
University Hospital, Angers
Not applicable
110
Angers, Rennes
2025-09-05
Recruiting
AbbVie
Observational
2,795
Dijon, Besançon, Bordeaux, Toulouse, Rennes, Chambray-lès-Tours, La Tronche, Lorient
2025-09-02
Not yet open
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863HEPATITIS C (HCV), Hepatitis B Virus (HBV), Hepatitis D, Hepatocellular Carcinoma (HCC)
Hospices Civils de Lyon
Not applicable
2,000
Annecy, Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Lille, Lyon, Rennes
2025-09-01
Recruiting
Central Hospital, Nancy, France
Not applicable
103
Bron, La Tronche, Montpellier, Nantes, Paris, Pessac, Rennes, Rouen
2025-08-29
Active, closed
Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM
NCT07213583Amyloid Transthyretin Cardiomyopathy
DrugCliramitug
Neurimmune AG
Phase 2
35
Créteil, Rennes, Toulouse
2025-08-28
Recruiting
Basilea Pharmaceutica
Phase 3
234
Nantes, Paris, Rennes, Strasbourg
2025-08-26
Recruiting
Wayshine Biopharm, Inc.
Phase 2
40
Rennes, Limoges, Pessac, Caen, Toulon
2025-08-18
Recruiting
AstraZeneca
Phase 2
278
Avignon, Paris, Rennes, Saint-Herblain, Suresnes
2025-08-07
Recruiting
Pfizer
Phase 3
400
Rennes, Brest, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy, Bron, Lyon, Pierre-Bénite
2025-08-05
Active, closed
Vir Biotechnology, Inc.
Phase 2
100
Clichy, Créteil, Limoges, Rennes, Toulouse
2025-08-05
Recruiting
CongenItal Naevus Cohort for Longitudinal Evaluation
NCT06828822Naevi, Neurodevelopmental Disorder, Congenital Nevus
Nantes University Hospital
Not applicable
819
Nice, Marseille, Dijon, La Réunion, Brest, Bordeaux, Toulouse, Rennes
2025-07-23
Recruiting
Pfizer
Phase 3
714
Pessac, Quimper, Toulouse, Rennes, Montpellier, Saint-Herblain, Cholet, Toulon
2025-07-23
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Caen, Clichy, Lille, Lyon, Marseille, Montpellier, Nantes, Rennes
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
586
Marseille, Tours, Toulouse, Lille, Rennes, Saint-Herblain, Nancy, Bron
2025-07-21
Active, closed
Compugen Ltd
Phase 1/2
60
Besançon, Toulouse, Lille, Marseille, Pierre-Bénite, Rennes, Saint-Herblain, Villejuif
2025-07-21
Active, closed
Lyv Healthcare
Not applicable
400
Aix-en-Provence, Caen, Rennes, Bordeaux, Le Chesnay, Le Mans, Lille, Paris
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Strasbourg, Toulouse, Rennes, Vandœuvre-lès-Nancy, Villejuif
2025-07-20
Recruiting
Daiichi Sankyo
Phase 1
76
Herblain, Rennes
2025-07-17
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Toulouse, Montpellier, Rennes, Strasbourg, Paris
2025-07-14
Recruiting
Poitiers University Hospital
Not applicable
114
Garches, Montpellier, Poitiers, Rennes, Saint-Etienne, Toulouse
2025-07-09
Recruiting
Orvida Pharma (formerly Kamari Pharma)
Phase 1
64
Paris, Rennes
2025-07-08
Recruiting
Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome
NCT06889974Renal Replacement Therapy for Acute Kidney Injury in ICU
University Hospital, Bordeaux
Observational
800
Angers, Bordeaux, Brest, Limoges, Nantes, Orléans, Pau, Rennes
2025-07-01
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Marseille, Dijon, Saint-Cloud, Montpellier, Rennes, Pierre-Bénite, Amiens, Créteil
2025-06-30
Active, closed
Calluna Pharma AS
Phase 2
150
Bobigny, Paris, Rennes, Toulouse, Tours
2025-06-20
Recruiting
Nantes University Hospital
Not applicable
362
Angers, Bordeaux, Grenoble, Lyon, Marseille, Nantes, Paris, Rennes
2025-06-17
Recruiting
GlaxoSmithKline
Phase 1/2
346
Dijon, Marseille, Paris, Poitiers, Rennes, Villejuif
2025-06-11
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Bordeaux, Marseille, Montpellier, Nantes, Paris, Rennes, Rouen
2025-05-21
Active, closed
UroMems SAS
Not applicable
140
Lille, Marseille, Nantes, Paris, Pierre-Bénite, Rennes, Rouen, Suresnes
2025-05-19
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Bordeaux, Créteil, Le Kremlin-Bicêtre, Rennes, Toulouse
2025-05-12
Recruiting
AstraZeneca
Phase 3
1,220
Clichy, Lille, Lyon, Montpellier, Nantes, Nice, Pessac, Rennes
2025-05-06
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Strasbourg, Marseille, Montpellier, Rennes, La Tronche, Saint-Herblain, Léon, Lille
2025-05-06
Active, closed
Mediar Therapeutics
Phase 2
168
Nantes, Nice, Rennes
2025-05-05
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
5,000
Angers, Besançon, Dijon, Nantes, Rennes
2025-05-05
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329Progressive Pulmonary Fibrosis, Interstitial Lung Disease
University of Massachusetts, Worcester
Observational
500
Paris, Rennes
2025-05-01
Recruiting
Institut Cancerologie de l'Ouest
Phase 3
84
Brest, Caen, Chambray-lès-Tours, Dijon, Le Havre, Lyon, Rennes, Saint-Herblain
2025-04-29
Recruiting
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
NCT06906601Breast Cancer, Medico-economic Impact, Breast Cancer Surgery
Centre Leon Berard
Observational
772
Lyon, Nancy, Pontoise, Reims, Rennes, Villejuif
2025-04-15
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
Rennes, Chambray-lès-Tours, Paris
2025-04-11
Recruiting
Hoffmann-La Roche
Phase 3
450
Angers, Lille, Montpellier, Paris, Plérin, Poitiers, Rennes, Rouen
2025-04-09
Recruiting
Gilead Sciences
Phase 3
695
Angers, Créteil, La Tronche, Lyon, Marseille, Paris, Pessac, Rennes
2025-04-04
Recruiting
University Hospital, Brest
Not applicable
217
Angers, Brest, Nantes, Rennes, Tours
2025-03-27
Recruiting
Rennes University Hospital
Phase 4
400
Chambray-lès-Tours, Clichy, Lille, Lyon, Montpellier, Pessac, Rennes, Villejuif
2025-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Marseille, Rennes, Lille, Villejuif
2025-03-25
Recruiting
Rennes University Hospital
Not applicable
50
Angers, Brest, Rennes
2025-03-22
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Cholet, Laval, Rennes, Vannes
2025-03-19
Recruiting
Hoffmann-La Roche
Phase 3
600
Amiens, Marseille, Nice, Pessac, Reims, Rennes, Saint-Etienne
2025-03-17
Recruiting
Center Eugene Marquis
Phase 2
34
Bobigny, Bordeaux, Clichy, Nantes, Rennes, Villejuif
2025-03-12
Recruiting
Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
NCT06582212Digital Technology, Mobile Application, Motor Fluctuations, Oestrogen
University Hospital, Grenoble
Not applicable
100
Grenoble, Nantes, Rennes, Toulouse
2025-03-12
Recruiting
177Lu-DOTATATE for Recurrent Meningioma
NCT06326190Recurrent Meningioma
DrugsLuTate·Lutathera
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Lyon, Marseille, Rennes, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2025-03-10
Recruiting
Rennes University Hospital
Phase 1
10
Créteil, Rennes
2025-03-06
Recruiting
Emobot
Not applicable
104
Agen, Caen, Laxou, Maxéville, Nantes, Paris, Reims, Rennes
2025-03-05
Recruiting
Hoffmann-La Roche
Phase 2
130
La Tronche, Montpellier, Pessac, Rennes, Tours
2025-03-05
Recruiting
AstraZeneca
Phase 3
840
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Poitiers, Rennes
2025-03-01
Recruiting
Hospital Center Guillaume Régnier
Observational
16
Rennes
2025-03-01
Not yet open
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
NCT06869005Childhood Cancer, Nausea with Vomiting Chemotherapy-Induced
Rennes University Hospital
Observational
150
Angers, Caen, Rennes, Saint-Herblain, Tours
2025-03
Recruiting
Tensi+ European Post-Market Clinical Follow-Up
NCT07205445Overactive Bladder
Stimuli Technology
Observational
500
Bron, Rennes, Rouen
2025-02-27
Active, closed
Amgen
Phase 2
252
Pierre-Bénite, Rennes, Suresnes
2025-02-26
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Montpellier, Nancy, Rennes
2025-02-24
Recruiting
WINNCARE
Not applicable
54
Ploemeur, Rennes
2025-02-11
Active, closed
Genmab
Phase 3
584
Nice, Paris, Pierre-Bénite, Rennes, Saint-Herblain, Toulouse, Villejuif
2025-02-07
Recruiting
BioNTech SE
Phase 3
621
Angers, Bordeaux, Caen, Paris, Rennes, Saint-Herblain, Toulon
2025-02-03
Not yet open
University of Rennes 2
Observational
10
Rennes
2025-02
Recruiting
Nantes University Hospital
Observational
200
Angers, Nantes, Rennes
2025-01-30
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Amiens, Bordeaux, Lille, Lyon, Paris, Rennes, Saint-Grégoire, Strasbourg
2025-01-28
Recruiting
UNICANCER
Phase 2
170
Rennes
2025-01-25
Recruiting
Belief Update: The Effects of Depression and Antidepressants in Older People
NCT07681492Major Depressive Episode (MDE), Beliefs, Beliefs About Future, Depression
Hospital Center Guillaume Régnier
Not applicable
62
Rennes
2025-01-14
Recruiting
Bronchiolitis Clearance Airways With Seaserum
NCT06177197Bronchiolitis Acute
University Hospital, Brest
Not applicable
458
Brest, Le Mans, Lille, Marseille, Morlaix, Nantes, Rennes, Tours
2025-01-10
Recruiting
Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
NCT06987461Bronchial Dilatation Disease, Bronchectasie
Centre Hospitalier Intercommunal Creteil
Observational
70
Créteil, Dijon, Rennes, Toulouse
2025-01-06
Active, closed
Pfizer
Phase 3
1,035
Bayonne, Bordeaux, Lille, Saint-Cloud, Rennes, Montpellier, Saint-Herblain, Angers
2025-01-06
Active, closed
Chemical and Microbiological Exposure of Women on Dairy Cattle Farms
NCT06709989Occupational Exposure to Chemicals
Institut National de la Santé Et de la Recherche Médicale, France
Observational
80
Rennes
2025-01-03
Recruiting
Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia
NCT06602934Hospital Acquired Pneumonia (HAP), Cardiovascular and Respiratory Disease
Nantes University Hospital
Not applicable
300
Angers, Nantes, Rennes, Rouen, Toulouse
2025-01-02
Active, closed
Boehringer Ingelheim
Phase 2
90
Lyon, Rennes
2024-12-30
Recruiting
Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)
NCT07258914Autism Spectrum Disorder, Depression, Major Depressive Episode (MDE)
Hospital Center Guillaume Régnier
Not applicable
25
Rennes
2024-12-19
Recruiting
Cytokinetics
Phase 3
1,800
Toulouse, Valenciennes, Rennes, La Tronche, Montpellier, Nantes, Bron, Toulon
2024-12-19
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
60
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Toulouse
2024-12-18
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Brest, Lille, Lyon, Marseille, Paris, Rennes
2024-12-17
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Bron, Montpellier, Nancy, Rennes
2024-12-12
Recruiting
Hospices Civils de Lyon
Not applicable
722
Bron, Dijon, Montpellier, Nancy, Paris, Pessac, Rennes, Saint-Herblain
2024-12-12
Recruiting
Basilea Pharmaceutica
Phase 3
450
Amiens, Argenteuil, Marseille, Nantes, Rennes, Tours
2024-12-11
Recruiting
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
NCT06481813Lung Cancer, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Metastatic Lung Cancer
Nantes University Hospital
Not applicable
730
Angers, Nantes, Rennes, Tours
2024-12-10
Active, closed
Systematic Intervention to Improve Sexual Dysfunction
NCT06583460Breast Cancer Female, Localized Cancer
Center Eugene Marquis
Not applicable
60
Rennes
2024-12-09
Recruiting
University Hospital, Limoges
Not applicable
756
Angers, Limoges, Poitiers, Rennes, Toulouse, Tours
2024-12-09
Recruiting
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT06392997Gynecologic Disease, Gynecologic Cancer, Endometriosis, Ovarian Cancer
ZIWIG
Observational
2,500
Angers, Bordeaux, Caen, Dijon, Lyon, Neuilly-sur-Seine, Rennes, Rouen
2024-12-05
Recruiting
MOLyF : Bone Marrow and Follicular Lymphoma
NCT06608147Lymphoma, Follicular
Rennes University Hospital
Not applicable
200
Rennes
2024-12-04
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Créteil, Marseille, Paris, Rennes, Toulouse
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Rennes, Lille, Bordeaux, Montpellier, Toulouse, Marseille, Paris
2024-12-03
Recruiting
Epidemiology of Gonococcal Arthritis (EpGAr)
NCT06897943Gonococcal (GC) Infection, Arthritis, Infectious
University Hospital, Brest
Observational
11
Rennes, Brest
2024-12-01
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-27
Recruiting
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
NCT06159764Syncope, Vasovagal, Bradycardia, Heart Arrest
University Hospital, Bordeaux
Observational
50
Bron, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris, Pessac, Rennes
2024-11-27
Recruiting
Tight Control for Rotator Cuff Tendinopathy
NCT06517680Rotator Cuff Tendinopathy
Nantes University Hospital
Not applicable
156
Angers, Brest, Chambray-lès-Tours, Cholet, La Roche-sur-Yon, Le Mans, Nantes, Rennes
2024-11-25
Recruiting
AstraZeneca
Phase 3
1,160
Avignon, La Rochelle, Lyon, Nîmes, Rennes, Strasbourg, Suresnes, Toulon
2024-11-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Rennes, Toulon, Bayonne, Grenoble, Montpellier, Paris
2024-11-18
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Angers, Bordeaux, Caen, Dijon, Montpellier, Nantes, Paris, Rennes
2024-11-15
Not yet open
Assessing the Ompact of Neutral Pelvic Positioning on Bone Repositioning Quality in Pelvic Radiotherapy Patients
NCT06687200Radiotherapy, Repositonning Pelvic, Neutral Pelvic Positioning
Centre Leon Berard
Not applicable
200
Lyon, Nancy, Rennes, Saint-Herblain
2024-11-15
Recruiting
Rennes University Hospital
Observational
400
Rennes
2024-11-12
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Lyon, Clichy, Rennes
2024-11-03
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Observational
100
Paris, Caen, Lyon, Marseille, Montpellier, Nîmes, Rennes, Strasbourg
2024-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Bordeaux, Dijon, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2024-10-29
Active, closed
Revolution Medicines, Inc.
Phase 3
500
Marseille, Rennes, Villejuif
2024-10-16
Recruiting
Cutting Edge SAS
Not applicable
58
Montauban, Rennes
2024-10-14
Recruiting
Rennes University Hospital
Observational
80
Nîmes, Paris, Rennes, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-10-11
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Dijon, Le Mans, Lille, Montpellier, Paris, Rennes, Strasbourg, Toulouse
2024-10-09
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Dijon, Brest, Toulouse, Montpellier, Rennes, Vandœuvre-lès-Nancy, Lille, Le Mans
2024-10-07
Recruiting
RAT-HEMATO : Return to Work After Malignant Hemopathy
NCT06262789Leukemia, Lymphoma, Multiple Myeloma
University Hospital, Angers
Not applicable
264
Angers, Brest, Caen, Cholet, Montivilliers, Morlaix, Rennes, Rouen
2024-09-27
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Chambray-lès-Tours, Marseille, Paris, Poitiers, Rennes, Toulouse
2024-09-24
Recruiting
Rennes University Hospital
Not applicable
1,680
Lille, Limoges, Paris, Pierre-Bénite, Plérin, Rennes, Rouen, Saint-Etienne
2024-09-23
Recruiting
AbbVie
Phase 2
590
Nice, Montpellier, Rennes, Vandœuvre-lès-Nancy, Pessac, Toulouse, St-Priest-en-Jarez, Pierre-Bénite
2024-09-04
Recruiting
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes
NCT06111950Taybi Linder Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Types I and III, Roifman Syndrome, Lowry Wood Syndrome
Hospices Civils de Lyon
Not applicable
45
Bordeaux, Bron, Dijon, Lille, Paris, Rennes
2024-08-27
Active, closed
Kite, A Gilead Company
Phase 3
452
Lille, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers, Rennes
2024-08-23
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
Rennes, Le Plessis-Robinson, Pessac
2024-08-21
Recruiting
Octapharma
Phase 3
120
Reims, Rennes
2024-08-21
Active, closed
Pfizer
Observational
450
Bordeaux, Argenteuil, Caen, Dijon, La Tronche, Lille, Rennes, Rouen
2024-08-07
Recruiting
Daiichi Sankyo
Phase 1/2
123
Lille, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Suresnes, Villejuif
2024-07-22
Recruiting
COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NCT06425614On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion
University Hospital, Bordeaux
Not applicable
570
Bordeaux, Bron, Montpellier, Nantes, Paris, Rennes, Strasbourg, Toulouse
2024-07-15
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 1/2
25
Bordeaux, Créteil, Lille, Rennes, Tours, Villejuif
2024-07-10
Recruiting
Nantes University Hospital
Not applicable
1,206
Brest, Rennes, Nantes, Angers, Tours
2024-07-08
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
60
Rennes
2024-07-03
Recruiting
Rennes University Hospital
Not applicable
50
Rennes
2024-07-02
Recruiting
Rennes University Hospital
Not applicable
180
Rennes, Tours
2024-07-01
Recruiting
Hospital Center Guillaume Régnier
Observational
30
Rennes
2024-07-01
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Bordeaux, Caen, Lyon, Marseille, Paris, Rennes, Saint-Herblain, Strasbourg
2024-06-28
Active, closed
First Observatory of Precocious Puberty.
NCT06263868Puberty, Precocious
Hospices Civils de Lyon
Observational
3,360
Écully, Lyon, Rennes, Chambray-lès-Tours, Essey-lès-Nancy, Levallois-Perret, Fondettes, Lormont
2024-06-26
Active, closed
Nantes University Hospital
Not applicable
750
Angers, Brest, Caen, Le Mans, Nantes, Poitiers, Pontoise, Rennes
2024-06-24
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Nice, Marseille, Montpellier, Rennes, Saint-Herblain, Paris, Bron, Lyon
2024-06-19
Active, closed
GlaxoSmithKline
Phase 3
88
Angers, Boulogne-Billancourt, Limoges, Lorient, Pessac, Rennes
2024-06-10
Active, closed
Exelixis
Phase 2/3
600
Marseille, Bordeaux, Rennes, Saint Priest En Jarez, Lyon, Le Mans, Villejuif, Dijon
2024-06-07
Recruiting
X4 Pharmaceuticals
Phase 3
176
Lyon, Paris, Rennes, Toulouse
2024-06-06
Recruiting
MabQuest SA
Phase 1
30
Lyon, Paris, Rennes, Toulouse
2024-06-06
Recruiting
Center Eugene Marquis
Observational
120
Rennes
2024-06-06
Recruiting
Centre Oscar Lambret
Not applicable
377
Lyon, Besançon, Rennes, Strasbourg, Lille, Poitiers, Toulouse, Saint-Herblain
2024-05-29
Recruiting
University Hospital, Angers
Not applicable
120
Angers, Lille, Lyon, Marseille, Nancy, Paris, Rennes
2024-05-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Bordeaux, Lyon, Caen, Toulouse, Lille, Rennes, Poitiers, Paris
2024-05-03
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Bourdeaux, Lille, Marseille, Paris, Rennes, Toulouse
2024-05-01
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Lille, Limoges, Lyon, Marseille, Paris, Quint-Fonsegrives, Rennes, Toulouse
2024-04-18
Recruiting
Daiichi Sankyo
Phase 1/2
680
Dijon, Bordeaux, Montpellier, Rennes, Saint-Herblain, Paris, Lyon, Villejuif
2024-04-10
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Lille, Limoges, Marseille, Paris, Quint-Fonsegrives, Rennes, Suresnes
2024-04-09
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
398
Rennes, Tours, Metz, Lyon, Montpellier, Angers, Le Kremlin-Bicêtre, Paris
2024-04-03
Active, closed
Novo Nordisk A/S
Phase 3
673
Chambray-lès-Tours, Poitiers, Rennes, Rouen, Toulon, Valenciennes, Vandœuvre-lès-Nancy
2024-04-01
Recruiting
GlaxoSmithKline
Phase 3
864
Ars-Laquenexy, Caen, Dijon, Marseille, Poitiers, Quimper, Rennes, Rouen
2024-03-21
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Pessac, Rennes, Toulouse
2024-03-15
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Paris, Pessac, Poitiers, Rennes
2024-03-07
Recruiting
Takeda
Phase 3
50
Lyon, Rennes, Val-de-Marne
2024-03-01
Recruiting
earlY Upper Limb Rehabilitation WIth EEG-Neurofeedback After Stroke
NCT05884762Stroke, Stroke Hemorrhagic, Stroke, Ischemic, Stroke Rehabilitation
Rennes University Hospital
Not applicable
40
Rennes
2024-02-20
Active, closed
Boehringer Ingelheim
Phase 3
428
Bron, Lyon, Marseille, Paris, Rennes, Strasbourg, Toulouse, Villejuif
2024-02-09
Recruiting
Association Francaise pour la Recherche Thermale
Not applicable
110
Bordeaux, Créteil, Dijon, Grenoble, Levallois-Perret, Marseille, Mougins, Rennes
2024-01-29
Active, closed
Sanofi
Phase 3
260
Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes, Vandœuvre-lès-Nancy
2024-01-23
Recruiting
Rennes University Hospital
Not applicable
16
Rennes
2024-01-23
Recruiting
Rennes University Hospital
Not applicable
50
Rennes
2024-01-18
Recruiting
FH ORTHO
Not applicable
800
Guilherand-Granges, Oyonnax, Reims, Rennes, Saint-Herblain
2024-01-08
Recruiting
Rennes University Hospital
Not applicable
20
Rennes
2024-01-08
Recruiting
University Hospital, Tours
Phase 3
374
Angers, Lyon, Nice, Nîmes, Rennes, Rouen, Toulouse, Tours
2024-01-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Lille, Strasbourg, Nîmes, Rennes, Clermont-Ferrand, Bayonne, Villejuif, Paris
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Rennes, Tours, Limoges, Vandœuvre-lès-Nancy, Roubaix, Pierre-Bénite, Paris
2023-12-31
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Marseille, Rennes, Tours, Bordeaux, Pessac, Lille, Rouen, Nantes
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Quimper, Rennes, Tours, Bordeaux, Pessac, Poitiers, Lille, Nantes
2023-12-13
Recruiting
Intellia Therapeutics
Phase 3
1,200
Créteil, Marseille, Paris, Rennes, Toulouse
2023-12-13
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Dijon, Rennes, Bordeaux, Lyon, Villejuif
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Rennes, Tours, Nantes, Marseille, Poitiers, Angers, Paris, Strasbourg
2023-12-12
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Amiens, Brest, Dijon, Rennes
2023-12-11
Active, closed
AstraZeneca
Phase 3
760
Marseille, Montpellier, Pessac, Rennes, Strasbourg, Toulouse, Villejuif
2023-12-04
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
DrugsBGB-43395·Elacestrant·Letrozole·Fulvestrant
BeOne Medicines
Phase 1
433
Bordeaux, Caen, Lille, Marseille, Paris, Rennes, Saint-Herblain, Villejuif
2023-12-01
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Amiens, Brest, Créteil, Grenoble, Paris, Rennes, Saint-Denis, Toulouse
2023-11-16
Recruiting
Takeda
Phase 3
80
Rennes, La Tronche, Nantes, Paris
2023-11-13
Recruiting
University Hospital, Angers
Not applicable
200
Angers, Brest, Nantes, Rennes, Tours
2023-11-09
Active, closed
AstraZeneca
Phase 3
314
Bordeaux, Brest, Paris, Rennes, Strasbourg, Toulouse
2023-11-08
Recruiting
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
NCT06080659Alzheimer Disease, Early Onset, Parkinson Disease
Rennes University Hospital
Not applicable
120
Rennes
2023-11-06
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Rennes, Clichy, Grenoble, Clermont-Ferrand, Créteil, Lille, Montpellier, Nantes
2023-11-03
Active, closed
Amgen
Phase 3
633
Poitier, Rennes, Lille
2023-11-02
Active, closed
Ipsen
Observational
1,057
Bordeaux, Caen, Rennes, Saint-Genis-Laval, Saint-Jacques
2023-11-01
Recruiting
Rennes University Hospital
Not applicable
150
Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Nantes, Paris, Rennes
2023-10-23
Recruiting
AbbVie
Phase 3
1,500
Nice, Rennes, Bordeaux, Toulouse, Reims, Nantes, Lyon, Brest
2023-10-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Grenoble, Chambray-lès-Tours, Orléans, Dijon, Le Coudray, Nîmes, Limoges, Rennes
2023-10-09
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Marseille, Montpellier, Paris, Rennes, Toulouse
2023-10-02
Active, closed
Asten Sante
Not applicable
556
La Roche-sur-Yon, Paris, Angers, Dijon, Le Chesnay, Le Mans, Nancy, Rennes
2023-09-29
Recruiting
Abbott Medical Devices
Observational
1,000
Massy, Montpellier, Paris, Rennes, Toulouse
2023-09-29
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Lille, Lyon, Marseille, Montpellier, Nantes, Pessac, Rennes, Rouen
2023-09-18
Active, closed
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
NCT05869955Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, Rheumatoid Arthritis
DrugsZola-cel·Tocilizumab·Fludarabine·Cyclophosphamide
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
270
Pessac, Montpellier, Lille, Nice, Paris, Rennes
2023-09-13
Recruiting
Biotest
Phase 3
590
Nice, Reims, Strasbourg, Colombes, Limoges, Rennes, Tours, Grenoble
2023-09-09
Active, closed
Boehringer Ingelheim
Phase 2
268
Amiens, Montpellier, Rennes
2023-09-08
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Clermont-Ferrand, La Tronche, Lille, Montpellier, Nantes, Paris, Pessac, Rennes
2023-09-01
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Bordeaux, Lyon, Paris, Rennes, Villejuif
2023-08-31
Recruiting
Isokinetic Strength Training in Hemiparetic Patient With Knee Extension Thrust
NCT05887440Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis), Gait Disorder
Rennes University Hospital
Not applicable
12
Rennes
2023-08-21
Recruiting
GlaxoSmithKline
Phase 3
892
Lyon, Marseille, Nantes, Paris, Pessac, Rennes, Rouen, Saint-Priest-en-Jarez
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Recruiting
Onward Therapeutics
Phase 1
150
Montpellier, Paris, Rennes
2023-07-10
Recruiting
Pain Management of Amputation Wounds With AutoHypnosis
NCT05779852Vascular Surgical Procedures
Rennes University Hospital
Not applicable
44
Rennes
2023-06-29
Active, closed
AstraZeneca
Phase 3
111
Bobigny, Clichy, Créteil, Marseille, Rennes
2023-06-27
Recruiting
Innate Pharma
Phase 2
70
Angers, Caen, Lille, Limoges, Lyon, Marseille, Rennes, Rouen
2023-06-23
Recruiting
Servier Affaires Médicales
Phase 3
245
Marseille, Caen, Toulouse, Rennes, Angers
2023-06-14
Recruiting
Hoffmann-La Roche
Phase 3
420
Avignon, Bayonne, Bordeaux, Lyon, Montpellier, Rennes, Toulouse
2023-06-07
Active, closed
Amgen
Phase 3
509
Grenoble, Lille, Limoges, Lyon, Marseille, Paris, Pierre-Bénite, Rennes
2023-05-31
Active, closed
Grey Wolf Therapeutics
Phase 1/2
300
Lyon, Marseille, Rennes, Saint-Herblain, Strasbourg, Toulouse, Villejuif
2023-05-21
Recruiting
University Hospital, Angers
Observational
120
Angers, Brest, Nantes, Poitiers, Rennes, Tours
2023-05-17
Recruiting
Agnes
Phase 3
30
Rennes
2023-05-12
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Bron, Lille, Paris, Rennes, Strasbourg
2023-05-09
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
82
Paris, Rennes
2023-05-04
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
90
Rennes
2023-05-03
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Lyon, Paris, Rennes, Strasbourg
2023-04-25
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
DrugsPanitumumab·Folfox·Cetuximab·Nab-paclitaxel
Institut de Recherches Internationales Servier
Phase 1/2
554
Dijon, Paris, Rennes, Villejuif
2023-04-18
Active, closed
University Hospital, Strasbourg, France
Not applicable
200
Lyon, Nantes, Nice, Reims, Strasbourg, Marseille, Rennes, Saint-Herblain
2023-04-04
Active, closed
GlaxoSmithKline
Phase 2
154
Besançon, Marseille, Paris, Pessac, Rennes
2023-04-03
Active, closed
Bayer
Phase 3
985
Clermont-Ferrand, La Tronche, Lyon, Pierre-Bénite, Besançon, Dijon, Brest, Rennes
2023-04-03
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Nantes, Nice, Nîmes, Paris, Rennes, Toulouse
2023-03-31
Recruiting
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
NCT05609084Epilepsy, Anomia, Temporal Lobe Epilepsy
Assistance Publique Hopitaux De Marseille
Not applicable
214
Bordeaux, Grenoble, Lille, Lyon, Marseille, Nancy, Paris, Rennes
2023-03-30
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Lille, Lyon, Nice, Paris, Poitiers, Rennes, Saint-Priest-en-Jarez
2023-03-22
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
DrugsELVN-002·Fam-Trastuzumab Deruxtecan-Nxki·Trastuzumab emtansine·Trastuzumab deruxtecan
Enliven Therapeutics
Phase 1
198
Marseille, Rennes, Caen, Bordeaux, Dijon, Lyon, Villejuif
2023-03-20
Recruiting
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NCT05699018Non-alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Fibrosis
University Hospital, Angers
Not applicable
1,788
Angers, Baugé-en-Anjou, Bécon-les-Granits, Chalonnes-sur-Loire, Combourg, Liffré, Montreuil-Bellay, Rennes
2023-03-13
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
177
Lille, Marseille, Nantes, Nice, Rennes, Toulouse
2023-03-10
Recruiting
Takeda
Phase 3
160
Clichy, Lyon, Pessac, Rennes, Toulouse, Val-de-Marne
2023-03-06
Recruiting
University Hospital, Rouen
Observational
2,500
Caen, Elbeuf, La Rochelle, Le Havre, Lille, Lomme, Rennes, Rouen
2023-03-01
Recruiting
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NCT06046131Prostatic Neoplasm, Adenocarcinoma, Neoplasm Recurrence, Neoplasm Metastasis
Centre Hospitalier Universitaire de la Guadeloupe
Not applicable
3,000
Rennes
2023-02-28
Recruiting
Mental Health and Sexuality in Adolescents and Young Adults
NCT05316948Psychiatric Disorder, Adolescent Behavior, Mental Health Issue
Fondation Santé des Étudiants de France
Observational
770
Vence, Grenoble, Rennes, Aire-sur-l'Adour, Vitry-le-François, Villeneuve-d'Ascq, Sablé-sur-Sarthe, Bouffémont
2023-02-27
Active, closed
AbbVie
Observational
300
Saint-Quentin, Clermont, Marseille, Rennes, Dijon, Niort, Besançon, Romans-sur-Isère
2023-02-21
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Lille, Lyon, Paris, Rennes, Strasbourg
2023-02-14
Active, closed
Kite, A Gilead Company
Phase 3
300
Bordeaux, Cedex Lyon 08, Dijon, Lille, Montpellier, Nice, Paris, Rennes
2023-02-10
Active, closed
Genmab
Phase 3
900
Nice, Clermont, Marseille, Rennes, Dijon, Limoges, Montpellier, La Tronche
2023-02-08
Recruiting
Medtronic Cardiovascular
Not applicable
400
Toulouse, Bordeaux, Créteil, Marseille, Nantes, Rennes, Saint-Denis, Tours
2023-02-07
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Caen, Chambéry, Le Mans, Lille, Rennes
2023-02-03
Active, closed
OFSEP Very High Definition Cohort
NCT05622643Multiple Sclerosis
EDMUS Foundation
Observational
300
Lyon, Nancy, Nîmes, Rennes, Strasbourg
2023-01-19
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Lille, Marseille, Nantes, Paris, Rennes, Strasbourg, Toulouse, Villeurbanne
2022-12-23
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
DrugsAZD9592·Osimertinib·Leucovorin·Adrucil
AstraZeneca
Phase 1
190
Marseille, Rennes, Villejuif
2022-12-21
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
NCT05751798Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
OSE Immunotherapeutics
Phase 1/2
41
Lyon, Paris, Rennes, Saint-Herblain, Toulouse, Villejuif
2022-12-20
Recruiting
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
NCT05752552Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor, Non-small Cell Lung Cancer
DeuterOncology
Phase 1
55
Bordeaux, Lille, Lyon, Marseille, Nice, Rennes, Villejuif
2022-12-20
Active, closed
Carmat SAS
Not applicable
104
Bron, Dijon, Le Plessis-Robinson, Lille, Montpellier, Nantes, Paris, Rennes
2022-12-12
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
DrugRamantamig
Janssen Research & Development, LLC
Phase 1
180
Nantes, Pierre-Bénite, Rennes, Toulouse
2022-11-22
Recruiting
University Hospital, Brest
Not applicable
240
Angers, Besançon, Brest, Caen, Grenoble, Nantes, Rennes, Strasbourg
2022-11-08
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Créteil, Lille, Lyon, Nantes, Paris, Pessac, Poitiers, Rennes
2022-10-25
Recruiting
Rennes University Hospital
Not applicable
50
Angers, Nantes, Rennes
2022-10-19
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Marseille, Rennes, Toulouse, Tours
2022-10-04
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Cholet, Lille, Lorient, Lyon, Paris, Rennes, Toulouse
2022-10-04
Recruiting
Alexis FERRE
Observational
2,000
Grenoble, Le Chesnay, Le Mans, Rennes
2022-10-01
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Neuilly-sur-Seine, Nice, Paris, Pierre-Bénite, Rennes, Vandœuvre-lès-Nancy
2022-09-27
Active, closed
Genmab
Phase 3
549
Clermont, Rennes, Caen, Dijon, Limoges, Nîmes, Reims, Vandœuvre-lès-Nancy
2022-09-20
Active, closed
Vir Biotechnology, Inc.
Phase 2
95
Clichy, Pessac, Rennes, Toulouse
2022-09-17
Recruiting
Modifying Factors in Striated Muscle Laminopathies
NCT05394506Laminopathies, Emery Dreifuss Muscular Dystrophy 2, LMNA-Related Congenital Muscular Dystrophy, Dilated Cardiomyopathy-1A
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
40
Bron, Paris, Montpellier, Rennes, Nantes, Rouen, Garches
2022-09-08
Active, closed
Genetics of Ventriculo-arterial Discordance
NCT05330338Heart Defects, Congenital
Nantes University Hospital
Not applicable
600
Marseille, Rennes, Bordeaux, Toulouse, Lille, Le Plessis-Robinson, Nantes, Saint-Herblain
2022-09-07
Recruiting
Intestinal Organoids
NCT05294107Digestive System Diseases, Inflammatory Bowel Disease, Ulcerative Colitis Type, Crohn Disease
Rennes University Hospital
Not applicable
90
Rennes
2022-09-06
Recruiting
Hospices Civils de Lyon
Observational
4
Lyon, Angers, Paris, Reims, Rennes
2022-09-06
Recruiting
Nantes University Hospital
Observational
80
Angers, Brest, Nantes, Paris, Rennes
2022-09-01
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Marseille, Caen, Besançon, Toulouse, Rennes
2022-08-08
Active, closed
AstraZeneca
Phase 3
341
Bobigny, Brest, Créteil, Dijon, Marseille, Paris, Poitiers, Rennes
2022-08-03
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Bordeaux, Lyon, Rennes, Villejuif
2022-08-03
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
La Roche-sur-Yon, Le Mans, Limoges, Nantes, Nice, Paris, Pierre-Bénite, Rennes
2022-07-22
Active, closed
The TRICURE First in Human Trial
NCT05126030Tricuspid Regurgitation
TRiCares
Not applicable
20
Bordeaux, Bron, Créteil, Lille, Marseille, Rennes, Saint-Denis
2022-07-15
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma, Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma, Hepatosplenic T-cell Lymphoma
DrugDibotatug
Dren Bio
Phase 1/2
200
Pierre-Bénite, Rennes, Toulouse
2022-07-13
Active, closed
Daiichi Sankyo
Phase 3
586
Brest, Caen, Lyon, Montpellier, Paris, Pierre-Bénite, Rennes, Saint-Herblain
2022-07-08
Recruiting
University Hospital, Brest
Observational
322
Angers, Brest, Caen, Chambéry, Lorient, Nantes, Quimper, Rennes
2022-06-21
Recruiting
University Hospital, Tours
Not applicable
200
Blois, Chinon, Dreux, Fleury-les-Aubrais, La Roche-sur-Yon, Neuilly-sur-Marne, Rennes, Saint-Maurice
2022-06-17
Active, closed
Genmab
Phase 2
264
Clermont, Rennes, Vandœuvre-lès-Nancy, Lille, Toulouse, Créteil, Nantes, Pierre-Bénite
2022-06-14
Active, closed
University Hospital, Angers
Observational
250
Angers, Corbeil-Essonnes, Créteil, Paris, Rennes
2022-05-30
Recruiting
Rennes University Hospital
Not applicable
50
Rennes
2022-05-25
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Amiens, Angers, Bordeaux, Lille, Lyon, Marseille, Paris, Rennes
2022-05-23
Recruiting
Rennes University Hospital
Not applicable
130
Rennes, Besançon, Le Mans, Tours
2022-05-20
Recruiting
Evaluation of Safe Use of SECURIDRAP® SELFIA®
NCT05510401Disorientation, Cognitive Impairment, Behavior Disorders
Groupe Mulliez-Flory
Not applicable
108
Bailleul, Bully-les-Mines, Hazebrouck, Le Quesnoy, Lille, Limoux, Lyon, Rennes
2022-05-18
Recruiting
Innovacell GmbH
Phase 3
290
Paris, Rennes, Rouen
2022-05-11
Active, closed
Pierre Fabre Medicament
Phase 3
815
Nice, Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Rennes, Chambray-lès-Tours
2022-05-02
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Rennes, Brest, Paris
2022-04-27
By invitation
AstraZeneca
Phase 3
214
Besançon, Bordeaux, Brest, Dijon, Lyon, Marseille, Montpellier, Rennes
2022-04-19
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Bordeaux, Lille, Lyon, Marseille, Rennes, Saint-Herblain, Toulouse, Villejuif
2022-04-14
Recruiting
AstraZeneca
Phase 2
630
Avignon, Bobigny, Bordeaux, Limoges, Rennes, Rouen, Suresnes, Toulon
2022-04-14
Recruiting
Rennes University Hospital
Not applicable
80
Rennes
2022-04-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Lyon, Strasbourg, Rennes, Chambray-lès-Tours, Besançon, Angers, Paris, Villejuif
2022-03-15
Recruiting
University of Melbourne
Phase 4
8,000
Rennes
2022-02-16
Recruiting
Center Eugene Marquis
Phase 2
62
Rennes, Pessac, Montpellier, Poitiers, Villejuif, Clichy, Créteil
2022-02-04
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
152
Bordeaux, Lille, Lyon, Paris, Poitiers, Reims, Rennes, Saint-Mandé
2022-01-19
Active, closed
Centre Leon Berard
Phase 2
58
Lyon, Bordeaux, Lille, Marseille, Nice, Poitiers, Reims, Rennes
2022-01-14
Recruiting
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
NCT05009927Metastatic Gastrointestinal Stromal Tumor (GIST), C-KIT Mutation, Advanced Gastrointestinal Stromal Tumor (GIST)
DrugsGlivec·Imatinib
Centre Leon Berard
Phase 2
50
Besançon, Bordeaux, Limoges, Lyon, Marseille, Paris, Reims, Rennes
2022-01-03
Active, closed
Rennes University Hospital
Observational
60
Lorient, Rennes, St-Malo, Vannes
2021-12-29
Active, closed
Lorlatinib Continuation Study
NCT05144997Non-Small-Cell Lung Cancer, NSCLC
DrugLorlatinib
Pfizer
Phase 4
76
Rennes, Villejuif
2021-12-28
Recruiting
University Hospital, Brest
Observational
100
Angers, Brest, Caen, Le Mans, Nantes, Rennes
2021-12-26
By invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309Solid and Hematological Malignancies, Autoimmune Diseases
DrugsKITE-197·SPRX002·KITE-753·Tecartus
Kite, A Gilead Company
Observational
1,500
Lille, Montpellier, Paris, Pessac, Pierre-Bénite, Rennes
2021-12-15
Active, closed
GlaxoSmithKline
Phase 2
360
Clichy, Lyon, Paris, Pessac, Rennes, Strasbourg
2021-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Brest, Caen, Limoges, Saint-Cloud, Rennes, Montpellier, Nantes
2021-12-13
Recruiting
UCB Biopharma SRL
Phase 3
350
Bron, Dijon, Marseille, Paris, Rennes, Strasbourg
2021-12-07
Recruiting
Centre Hospitalier Departemental Vendee
Not applicable
526
Bayonne, La Roche-sur-Yon, Le Puy-en-Velay, Nantes, Orléans, Rennes, Saint-Herblain
2021-12-07
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 2
222
Marseille, Paris, Pierre-Bénite, Rennes, Strasbourg, Toulouse, Villejuif
2021-12-01
Active, closed
Womed
Not applicable
160
Le Kremlin-Bicêtre, Lille, Marseille, Paris, Rennes
2021-11-29
Active, closed
Rennes University Hospital
Phase 3
106
Rennes, Amiens, Bordeaux, Caen, Cholet, Grenoble, Mulhouse, Nîmes
2021-11-24
Recruiting
Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care
NCT04220463Chronic Obstructive Pulmonary Disease (COPD), Obesity With a BMI Greater Than 30, Acute Respiratory Distress in Adult Intensive Care
Rennes University Hospital
Not applicable
50
Rennes
2021-11-20
Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216Acute Stroke, Ischemic Stroke, Stroke
DiaMedica Therapeutics Inc
Phase 2/3
728
Rennes, Bordeaux, Marseille, Nancy, Strasbourg
2021-11-07
Recruiting
Rennes University Hospital
Not applicable
600
Rennes
2021-11-04
Active, closed
Camurus AB
Phase 3
332
Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Nantes, Rennes, Strasbourg
2021-10-22
Active, closed
Hoffmann-La Roche
Phase 2
176
Besançon, Caen, Lyon, Paris, Rennes, Saint-Herblain, Toulouse, Villejuif
2021-10-07
Active, closed
Hoffmann-La Roche
Phase 3
217
Bordeaux, Lille, Lyon, Marseille, Rennes, Toulouse, Vantoux
2021-09-30
Active, closed
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
NCT04931654Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
DrugSabestomig
AstraZeneca
Phase 1/2
136
Bordeaux, Rennes, Villejuif
2021-09-28
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Rennes
2021-09-23
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Nantes, Pessac, Rennes, Toulouse
2021-09-22
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Le Mans, Montpellier, Morvan, Nantes, Paris, Pierre-Bénite, Politiers, Rennes
2021-09-20
Active, closed
Rennes University Hospital
Not applicable
148
Lorient, Rennes, Sélestat, St-Malo, Toulouse
2021-09-17
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bron, La Tronche, Lyon 08, Marseille, Paris, Poitiers, Reims, Rennes
2021-09-01
Active, closed
Inventiva Pharma
Phase 3
1,000
Lyon, Strasbourg, Marseille, Dijon, Besançon, Lille, Rennes, Grenoble
2021-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 2
730
Rennes, Besançon, Brest, Montpellier, La Tronche, Avignon, Clichy
2021-08-18
Recruiting
X-linked Moesin Associated Immunodeficiency
NCT06278337Immune Deficiency, Autoimmune Diseases, Infections, Diagnosis
Institut National de la Santé Et de la Recherche Médicale, France
Observational
16
Paris, Rennes, Saint-Etienne
2021-08-12
Recruiting
Genentech, Inc.
Phase 1
186
Paris, Poitiers, Rennes
2021-07-26
Recruiting
Centre Hospitalier Intercommunal Creteil
Observational
6,000
Bordeaux, Brest, Caen, Créteil, Rennes, Rouen, Toulon
2021-07-22
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Clichy, Créteil, Lyon, Montpellier, Paris, Rennes, Strasbourg, Tours
2021-07-08
Active, closed
Rennes University Hospital
Not applicable
239
Bobigny, Limoges, Lorient, Mulhouse, Orléans, Paris, Rennes, Saint-Brieuc
2021-07-02
Recruiting
Boehringer Ingelheim
Phase 1
554
Bron, Lyon, Marseille, Paris, Rennes, Villejuif
2021-07-02
Recruiting
HighLife SAS
Not applicable
30
Lille, Nantes, Rennes, Toulouse
2021-07-01
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
103
Marseille, Nîmes, Montpellier, Clichy, Dijon, Paris, Rennes, Villejuif
2021-06-16
Active, closed
Centre Jean Perrin
Not applicable
1,100
Clermont-Ferrand, Beaumont, Angers, Rennes, Saint-Herblain, Paris
2021-05-31
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Boulogne, Clermont-Ferrand, Lyon, Rennes
2021-05-21
Active, closed
Savara Inc.
Phase 3
164
Bron, Rennes
2021-05-19
By invitation
Cytokinetics
Phase 2/3
900
Marseille, Montpellier, Nantes, Paris, Pessac, Rennes, Toulouse
2021-05-06
Active, closed
Abbott Medical Devices
Observational
200
Bordeaux, Lille, Lyon, Rennes, Toulouse
2021-05-04
Recruiting
Hospices Civils de Lyon
Not applicable
330
Chambray-lès-Tours, Colombes, Lyon, Nantes, Pessac, Rennes, Rouen
2021-05-03
Active, closed
Hoffmann-La Roche
Phase 3
557
Grenoble, Lille, Marseille, Montpellier, Nantes, Paris, Pessac, Rennes
2021-04-26
Active, closed
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
NCT04825743ST-elevation Myocardial Infarction (STEMI)
CeleCor Therapeutics
Phase 3
2,463
Aubervilliers, Boulogne-Billancourt, Créteil, Grenoble, Marseille, Montreuil, Paris, Rennes
2021-04-24
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Bordeaux, Lille, Rennes, Toulouse
2021-04-15
Active, closed
IDEAYA Biosciences
Phase 1
169
Bordeaux, Toulouse, Marseille, Dijon, Rennes, Villejuif
2021-04-14
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Amiens, Le Mans, Nice, Nîmes, Pierre-Bénite, Rennes, Saint-Priest-en-Jarez, Tours
2021-04-09
Recruiting
University Hospital, Bordeaux
Not applicable
1,800
Clermont-Ferrand, Massy, Paris, Pessac, Rennes, Saint-Etienne, Toulouse, Vandœuvre-lès-Nancy
2021-04-06
Recruiting
Molecular Signature From Tumor to Lymph Nodes
NCT04677205Lung Cancer, Stage IIIA-cN2, Operated With Curative Intent, Primary Tumor Tissue Available
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Clamart, Marseille, Nice, Paris, Rennes, Strasbourg, Toulouse
2021-03-30
Active, closed
Rennes University Hospital
Not applicable
68
Rennes
2021-03-26
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
La Roche-sur-Yon, Lille, Lyon, Nîmes, Paris, Pierre-Bénite, Rennes, Saint-Herblain
2021-03-18
Active, closed
Janssen Research & Development, LLC
Phase 1
140
Lyon, Nantes, Pessac, Rennes, Toulouse
2021-03-12
Active, closed
Hoffmann-La Roche
Phase 3
270
Bordeaux, Créteil, Lille, Montpellier, Pierre-Bénite, Rennes
2021-02-23
Recruiting
Biosense Webster, Inc.
Observational
8,000
Clermont-Ferrand, Lyon, Marseille, Paris, Rennes, Strasbourg, Talence
2021-02-22
Recruiting
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
NCT04545502Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection
Vascutek Ltd.
Observational
2,000
Bordeaux, Clermont-Ferrand, Dijon, Lille, Marseille, Rennes, Strasbourg, Toulouse
2021-02-17
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Toulouse, Nantes, Lyon, Brest, Grenoble, Paris, Rennes, Villejuif
2021-02-02
Active, closed
Rennes University Hospital
Observational
150
Rennes
2021-01-21
Active, closed
Daiichi Sankyo
Phase 3
605
Besançon, Grenoble, Lyon, Marseille, Nantes, Paris, Poitiers, Rennes
2020-12-21
Recruiting
University Hospital, Limoges
Not applicable
430
Limoges, Poitiers, Rennes, Tours
2020-12-21
Active, closed
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NCT04225520Left Ventricular Dyssynchrony, Heart Failure, Cardiomyopathy, Dilated, Cardiac Remodeling, Ventricular
Universitaire Ziekenhuizen KU Leuven
Not applicable
500
Brest, Lille, Rennes
2020-12-10
Active, closed
GlaxoSmithKline
Phase 2/3
758
Créteil, Grenoble, Marseille, Nice, Quimper, Rennes, Tours
2020-12-08
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Annecy, Chambray-lès-Tours, Clermont-Ferrand, Grenoble, Lille, Rennes, Rouen, Toulouse
2020-12-03
Active, closed
Institut Cancerologie de l'Ouest
Phase 1/2
44
Angers, Brest, Chambray-lès-Tours, Dijon, Le Mans, Lille, Lyon, Rennes
2020-11-17
Active, closed
Bayer
Phase 4
654
La Tronche (Grenoble Area), Dijon, Brest, Rennes, Reims, Strasbourg, Vandœuvre-lès-Nancy, Bordeaux
2020-11-09
Active, closed
Septodont
Not applicable
160
Paris, Rennes, Rouen, Saint-Grégoire
2020-11-06
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Créteil, Lille, Massy, Nice, Rennes
2020-11-04
Active, closed
Hoffmann-La Roche
Phase 1/2
518
Dijon, Marseille, Rennes, Villejuif
2020-11-01
Active, closed
Bayer
Phase 3
774
Clermont-Ferrand, Pierre-Bénite, Dijon, Brest, Rennes, Tours, Reims, Bordeaux
2020-10-20
Active, closed
Hoffmann-La Roche
Phase 3
992
Angers, Bayonne, La Roche-sur-Yon, Montpellier, Poitiers, Reims, Rennes, Saint-Priest-en-Jarez
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Brest, Caen, Marseille, Montpellier, Nantes, Pessac, Pierre-Bénite, Rennes
2020-10-08
Active, closed
University Hospital, Brest
Not applicable
70
Angers, Bordeaux, Grenoble, Lyon, Nantes, Paris, Rennes, Roscoff
2020-10-02
Active, closed
University Hospital, Tours
Not applicable
100
Angers, Rennes, Saint-Herblain, Tours
2020-09-01
Active, closed
Hoffmann-La Roche
Phase 1/2
237
Pierre-Bénite, Rennes
2020-08-12
Active, closed
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms
DrugsZelenectide pevedotin·Keytruda·Pembrolizumab
BicycleTx Limited
Phase 1/2
329
Bordeaux, Lyon, Marseille, Rennes, Villejuif
2020-07-17
Active, closed
Celgene
Phase 2
276
Lille, Montpellier, Paris, Pierre-Bénite, Rennes, Toulouse
2020-07-14
Recruiting
Nantes University Hospital
Phase 3
110
Angers, Brest, Limoges, Nantes, Rennes, Tours
2020-06-19
Active, closed
Sanofi
Phase 3
337
Ars-Laquenexy, Bayonne, Grenoble, La Roche-sur-Yon, Lille, Paris, Poitiers, Rennes
2020-06-16
Active, closed
UNICANCER
Phase 3
180
Pierre-Bénite, Rennes
2020-06-11
Recruiting
High Resolution Imaging for Analysis of MVNT
NCT04285125Benign Neuronal Desease
Fondation Ophtalmologique Adolphe de Rothschild
Observational
33
Bordeaux, Rennes, Rouen, Toulouse, Paris, Pierre-Bénite, Saint-Herblain
2020-03-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Dijon, Montpellier, Rennes, Nantes, Paris
2020-02-27
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Recruiting
Nantes University Hospital
Phase 2
25
Bordeaux, Lyon, Nantes, Rennes
2020-02-06
Recruiting
Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
NCT04192825Crohn Disease, Anal Suppurations, Drainage Procedure
Rennes University Hospital
Observational
440
Rennes
2020-02-03
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Paris, Poitiers, Rennes
2020-01-29
Active, closed
MitraClip EXPAND G4 Study
NCT04177394Mitral Valve Regurgitation, Mitral Regurgitation
Abbott Medical Devices
Observational
1,164
Rennes, Toulouse
2020-01-17
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
95
Rennes, Bordeaux, Caen, Grenoble, Montpellier
2020-01-07
Recruiting
University Hospital, Limoges
Phase 2
40
Bordeaux, Bron, Le Kremlin-Bicêtre, Limoges, Paris, Rennes, Rouen, Toulouse
2020-01-06
Recruiting
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT03728049Aortic Valve Stenosis, Aortic Valve Insufficiency
University Hospital, Lille
Not applicable
944
Clermont-Ferrand, Lille, Montpellier, Nîmes, Paris, Pessac, Rennes, Strasbourg
2019-12-18
Active, closed
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922Primary Glioblastoma, Glioblastoma Multiforme
DrugLAM561
Laminar Pharmaceuticals
Phase 2/3
144
Angers, Rennes, Toulouse
2019-12-01
Active, closed
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
NCT04106908VWD - Von Willebrand's Disease
Octapharma
Observational
38
Caen, Clamart, Paris, Rennes, Rouen, Saint-Denis, Saint-Etienne
2019-11-27
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Brest, Caen, Le Kremlin-Bicêtre, Nantes, Rennes, Saint-Priest-en-Jarez
2019-11-13
Active, closed
Rennes University Hospital
Not applicable
37
Angers, Brest, Nantes, Poitiers, Rennes, Saint-Avé, St-Malo, Tours
2019-11-08
Active, closed
Ventricular Arrhythmia After Myocarditis in Sportsman
NCT03842592Myocarditis Acute, Ventricular Arrythmia
University Hospital, Angers
Not applicable
50
Angers, Brest, Paris, Rennes
2019-11-06
Active, closed
Bristol-Myers Squibb
Phase 3
461
Besançon, La Tronche, Montpellier, Paris, Rennes, Rouen
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Rennes, Brest, Marseille, Paris, Vandœuvre-lès-Nancy, Villejuif
2019-11-04
Recruiting
University Hospital, Strasbourg, France
Phase 2
40
Besançon, Nancy, Paris, Rennes, Strasbourg
2019-10-29
Active, closed
Novo Nordisk A/S
Phase 3
134
Bron, Clermont-Ferrand, Le Kremlin-Bicêtre, Rennes
2019-10-21
Recruiting
Cellectis S.A.
Phase 1/2
52
Nantes, Paris, Pierre-Bénite, Rennes
2019-10-14
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Toulouse, Rennes, Saint-Priest-en-Jarez, Créteil, Saint-Denis
2019-10-03
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Tours, Montpellier, Clermont-Ferrand, Rennes, Bordeaux, Caen, Dijon, La Tronche
2019-09-27
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Garches, Lille, Rennes, Strasbourg, Toulouse
2019-09-16
Active, closed
Nyxoah S.A.
Not applicable
110
Angers, Créteil, Lille, Montpellier, Paris, Rennes, Toulouse
2019-09-01
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808Unruptured Intracranial Aneurysm
Nantes University Hospital
Observational
1,000
Marseille, Brest, Bordeaux, Toulouse, Limoges, Rennes, Tours, Nantes
2019-08-19
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Lille, Montpellier, Pierre-Bénite, Rennes
2019-08-13
Recruiting
Oxford BioTherapeutics Ltd
Phase 1
200
Marseille, Paris, Rennes, Strasbourg, Villejuif
2019-07-25
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
217
Marseille, Paris, Pierre-Bénite, Rennes
2019-06-26
Active, closed
Exelixis
Phase 3
855
Bordeaux, Le Mans, Lyon, Montpellier, Nice, Paris, Reims, Rennes
2019-06-25
Active, closed
Eisai Inc.
Phase 2
100
Marseille, Bordeaux, Paris, Rennes, Toulouse
2019-05-31
Recruiting
HighLife SAS
Not applicable
120
Toulouse, Lille, Lyon, Massy, Nantes, Paris, Pessac, Rennes
2019-05-28
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Marseille, Nantes, Rennes, Tours
2019-04-26
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Strasbourg, Lyon, Clermont-Ferrand, Rennes, Besançon, Lille, Montpellier, Limoges
2019-03-28
Active, closed
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3
377
Nice, Caen, Rennes, Reims, Perpignan, Lyon, Villejuif, Montpellier
2019-03-28
Active, closed
Acerta Pharma BV
Phase 3
984
Montpellier, Paris, Rennes, Rouen, Toulouse, Villejuif
2019-02-25
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Active, closed
AstraZeneca
Phase 2
367
Dijon, Marseille, Nantes, Paris, Rennes
2019-01-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Dijon, Rennes, Suresnes, Lille, Créteil
2018-12-24
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Nice, Dijon, Limoges, Saint-Cloud, Rennes, Grenoble, Lyon, Amiens
2018-12-07
Active, closed
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NCT03438552Local Recurrence of Malignant Tumor of Prostate
UNICANCER
Not applicable
57
Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Montpellier, Paris, Rennes
2018-10-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Montpellier, Rennes, Angers
2018-09-12
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
315
Villejuif, Lille, Paris, Rennes
2018-08-29
Rows per page Showing 1–500 of 537
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/city/rennes

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 537 of those studies with a site in Rennes.

How many clinical trials are recruiting in Rennes?

301 of the 537 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 35 have not yet opened recruitment, 194 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rennes), 537 studies
PhaseStudiesRecruitingShare
Phase 31587429.4%
Not applicable15310028.5%
Observational846115.6%
Phase 2702813%
Phase 1/231155.8%
Phase 119123.5%
Phase 2/31382.4%
Phase 4931.7%

Most active sponsors

Lead sponsors with the most studies (Rennes)
Lead sponsorStudiesRecruiting
Rennes University Hospital4630
Nantes University Hospital2217
AstraZeneca2110
Hoffmann-La Roche165
Merck Sharp & Dohme LLC165
University Hospital, Angers1512
Novartis Pharmaceuticals144
University Hospital, Brest1110
Assistance Publique - Hôpitaux de Paris106
Boehringer Ingelheim106
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.